AI Verdict
IBTA has stronger fundamentals based on our AI analysis.
ICUI vs IBTA Fundamental Comparison
| Metric | ICUI | IBTA |
|---|---|---|
| Revenue | $2.2B | $342.4M |
| Net Income | $732,000.0 | $3.6M |
| Net Margin | 0.0% | 1.0% |
| ROE | 0.0% | 1.2% |
| ROA | 0.0% | 0.7% |
| Current Ratio | 2.39x | 1.96x |
| Debt/Equity | 0.60x | 0.00x |
| EPS | $0.03 | $0.12 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICUI vs IBTA: Frequently Asked Questions
Is ICUI or IBTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBTA has stronger fundamentals. ICUI is rated SELL (72% confidence) while IBTA is rated HOLD (68% confidence). This is not investment advice.
How does ICUI compare to IBTA fundamentally?
ICU MEDICAL INC/DE has ROE of 0.0% vs Ibotta, Inc.'s 1.2%. Net margins are 0.0% vs 1.0% respectively.
Which stock pays higher dividends, ICUI or IBTA?
ICUI has a dividend yield of N/A or no dividend while IBTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICUI or IBTA for long term?
For long-term investing, consider that ICUI has SELL rating with 72% confidence, while IBTA has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICUI vs IBTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICUI vs IBTA, the AI consensus favors IBTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.